Glutamine and Antioxidant Potential in Diabetes

Sung Ling Yeh, Yu-Chen Hou

研究成果: 書貢獻/報告類型章節

1 引文 (Scopus)

摘要

Glutamine (GLN) has many physiological functions in the body. Although it is a non-essential amino acid, GLN is considered conditionally essential for patients with catabolic conditions. Many studies have demonstrated the benefits of GLN administration on immune functions, and suggested that additional GLN supplementation is needed in stressed patients. Diabetes is a catabolic disease with high oxidative stress. Numerous studies found that GLN enhances the insulin response, reduces inflammatory mediator production, and decreases the expressions of genes associated with the main pathways that cause diabetic complications. GLN is the precursor of glutathione, and it enhances heat shock protein expression. Its supplementation increases antioxidant potential, which may play an important role in mitigating tissue injury induced by diabetes. Other factors, including attenuation of inflammatory reactions, decreases in cellular apoptosis, and enhancement of insulin secretion, may also contribute to the benefits of GLN in diabetes.

原文英語
主出版物標題Diabetes: Oxidative Stress and Dietary Antioxidants
發行者Elsevier Inc.
頁面121-128
頁數8
ISBN(列印)9780124058859
DOIs
出版狀態已發佈 - 十一月 2013

指紋

Glutamine
Antioxidants
Insulin
Diabetes Complications
Heat-Shock Proteins
Glutathione
Oxidative Stress
Apoptosis
Gene Expression
Amino Acids
Wounds and Injuries

ASJC Scopus subject areas

  • Medicine(all)
  • Dentistry(all)

引用此文

Yeh, S. L., & Hou, Y-C. (2013). Glutamine and Antioxidant Potential in Diabetes. 於 Diabetes: Oxidative Stress and Dietary Antioxidants (頁 121-128). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-405885-9.00012-7

Glutamine and Antioxidant Potential in Diabetes. / Yeh, Sung Ling; Hou, Yu-Chen.

Diabetes: Oxidative Stress and Dietary Antioxidants. Elsevier Inc., 2013. p. 121-128.

研究成果: 書貢獻/報告類型章節

Yeh, SL & Hou, Y-C 2013, Glutamine and Antioxidant Potential in Diabetes. 於 Diabetes: Oxidative Stress and Dietary Antioxidants. Elsevier Inc., 頁 121-128. https://doi.org/10.1016/B978-0-12-405885-9.00012-7
Yeh SL, Hou Y-C. Glutamine and Antioxidant Potential in Diabetes. 於 Diabetes: Oxidative Stress and Dietary Antioxidants. Elsevier Inc. 2013. p. 121-128 https://doi.org/10.1016/B978-0-12-405885-9.00012-7
Yeh, Sung Ling ; Hou, Yu-Chen. / Glutamine and Antioxidant Potential in Diabetes. Diabetes: Oxidative Stress and Dietary Antioxidants. Elsevier Inc., 2013. 頁 121-128
@inbook{ba8c301a28e445eeb047afe8c71ae938,
title = "Glutamine and Antioxidant Potential in Diabetes",
abstract = "Glutamine (GLN) has many physiological functions in the body. Although it is a non-essential amino acid, GLN is considered conditionally essential for patients with catabolic conditions. Many studies have demonstrated the benefits of GLN administration on immune functions, and suggested that additional GLN supplementation is needed in stressed patients. Diabetes is a catabolic disease with high oxidative stress. Numerous studies found that GLN enhances the insulin response, reduces inflammatory mediator production, and decreases the expressions of genes associated with the main pathways that cause diabetic complications. GLN is the precursor of glutathione, and it enhances heat shock protein expression. Its supplementation increases antioxidant potential, which may play an important role in mitigating tissue injury induced by diabetes. Other factors, including attenuation of inflammatory reactions, decreases in cellular apoptosis, and enhancement of insulin secretion, may also contribute to the benefits of GLN in diabetes.",
keywords = "Diabetes, Glutamine, Glutathione, Heat shock protein, Insulin secretion, Oxidative stress",
author = "Yeh, {Sung Ling} and Yu-Chen Hou",
year = "2013",
month = "11",
doi = "10.1016/B978-0-12-405885-9.00012-7",
language = "English",
isbn = "9780124058859",
pages = "121--128",
booktitle = "Diabetes: Oxidative Stress and Dietary Antioxidants",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Glutamine and Antioxidant Potential in Diabetes

AU - Yeh, Sung Ling

AU - Hou, Yu-Chen

PY - 2013/11

Y1 - 2013/11

N2 - Glutamine (GLN) has many physiological functions in the body. Although it is a non-essential amino acid, GLN is considered conditionally essential for patients with catabolic conditions. Many studies have demonstrated the benefits of GLN administration on immune functions, and suggested that additional GLN supplementation is needed in stressed patients. Diabetes is a catabolic disease with high oxidative stress. Numerous studies found that GLN enhances the insulin response, reduces inflammatory mediator production, and decreases the expressions of genes associated with the main pathways that cause diabetic complications. GLN is the precursor of glutathione, and it enhances heat shock protein expression. Its supplementation increases antioxidant potential, which may play an important role in mitigating tissue injury induced by diabetes. Other factors, including attenuation of inflammatory reactions, decreases in cellular apoptosis, and enhancement of insulin secretion, may also contribute to the benefits of GLN in diabetes.

AB - Glutamine (GLN) has many physiological functions in the body. Although it is a non-essential amino acid, GLN is considered conditionally essential for patients with catabolic conditions. Many studies have demonstrated the benefits of GLN administration on immune functions, and suggested that additional GLN supplementation is needed in stressed patients. Diabetes is a catabolic disease with high oxidative stress. Numerous studies found that GLN enhances the insulin response, reduces inflammatory mediator production, and decreases the expressions of genes associated with the main pathways that cause diabetic complications. GLN is the precursor of glutathione, and it enhances heat shock protein expression. Its supplementation increases antioxidant potential, which may play an important role in mitigating tissue injury induced by diabetes. Other factors, including attenuation of inflammatory reactions, decreases in cellular apoptosis, and enhancement of insulin secretion, may also contribute to the benefits of GLN in diabetes.

KW - Diabetes

KW - Glutamine

KW - Glutathione

KW - Heat shock protein

KW - Insulin secretion

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84902238709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902238709&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-405885-9.00012-7

DO - 10.1016/B978-0-12-405885-9.00012-7

M3 - Chapter

AN - SCOPUS:84902238709

SN - 9780124058859

SP - 121

EP - 128

BT - Diabetes: Oxidative Stress and Dietary Antioxidants

PB - Elsevier Inc.

ER -